STOCKWATCH
·
Ophthalmic Goods
AGM/EGMMay 4, 2026, 06:11 AM

National Vision Reports Strong 2025 Results; Sets 2026 Annual Meeting

AI Summary

National Vision Holdings, Inc. announced its 2026 Annual Meeting of Stockholders for June 17, 2026, where shareholders will vote on director elections, executive compensation, and auditor ratification. The company reported strong 2025 financial results, including a 9.0% increase in net revenue to $1,987.5 million and a 5.9% comparable store sales growth. Key corporate governance updates include the completion of the CEO succession plan with Alex Wilkes taking over as CEO and Reade Fahs becoming Executive Chairman, alongside board refreshment and changes to executive compensation programs.

Key Highlights

  • 2026 Annual Meeting of Stockholders scheduled for June 17, 2026.
  • Alex Wilkes appointed CEO in August 2025; Reade Fahs became Executive Chairman.
  • Net revenue increased 9.0% to $1,987.5 million in 2025.
  • Comparable store sales grew 5.9% (Adjusted 6.0%) in 2025.
  • Diluted EPS from continuing operations was $0.37 in 2025.
  • Adjusted Operating Income from continuing operations reached $102.5 million.
  • Store count grew 0.8% to 1,250 stores by end of 2025.
  • Repaid $101.3 million in long-term debt and convertible notes in 2025.
EYE
Ophthalmic Goods
National Vision Holdings, Inc.

Price Impact